Has Yasser Faraj, DO received payments from drug or device companies?

Yes. Drug and device makers reported $2,940 in general payments to Yasser Faraj, DO across 83 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Yasser Faraj, DO did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Yasser Faraj, DO come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Yasser Faraj, DO

Dermatology · Maitland, FLNPI 1043848229

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 93.9% of the total across 83 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 23 manufacturers reported payments, led by Sun Pharmaceutical Industries Inc. at 24.5% of the total. Reporting peaked in 2023 at $1,052 and has fallen 55.5% since, to $468 in 2025. That places this record below the midpoint for dermatology clinicians in FL, where the typical reported total is $2,563.

$2,940in general payments, 2019–2025

Across 83 payments — averaging $35.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Sun Pharmaceutical Industries Inc.$720
AbbVie$381
Johnson & Johnson$305
Regeneron Healthcare Solutions, Inc.$210
Sanofi$207
Lilly USA, LLC$171
plus $945 from 17 others

What the payments were for

Food & beverage$2,76194%
Education$1796%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Sun Pharmaceutical Industries Inc.	9	$720
AbbVie	17	$381
Johnson & Johnson	10	$305
Regeneron Healthcare Solutions, Inc.	4	$210
Sanofi	6	$207
Lilly USA, LLC	2	$171
Surgenex LLC	6	$148
Dermavant Sciences, Inc.	1	$145
UCB, Inc.	2	$119
LEO Pharma Inc.	4	$91
Kyowa Kirin, Inc.	2	$55
E.r. Squibb & Sons, L.L.C.	2	$49
Galderma Laboratories, L.p.	3	$44
Incyte Corporation	2	$43
Novartis	2	$41
Arcutis Biotherapeutics, Inc.	2	$39
Biofrontera Inc.	2	$37
Boehringer Ingelheim	2	$34
Ortho Dermatologics, A Division Of Bausch Health US, LLC	1	$31
Mimedx Group, Inc.	1	$23
Organogenesis Inc.	1	$20
Mayne Pharma Commercial LLC	1	$17
Biowound Solutions, Inc.	1	$9

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

VTAMA$145
OLUMIANT$145
DUPIXENT$120
ILUMYA$110
Winlevi$109

How this compares

$2,940 in reported general payments places this provider in the 50th percentile of 1,147 dermatology providers in Florida.

See all dermatology providers in Florida →

Medicare billing

Part B allowed, 2024

$585,626

Medicare patients

179

Services billed

1,098

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Doxycycline Hyclate	246	$2,235
Mupirocin	73	$600
Clobetasol Propionate	15	$505
Ketoconazole	26	$429
Triamcinolone Acetonide	22	$283

Paid to pharmacies, not to this prescriber.

Other dermatology in Maitland

Rajiv NathooMaitland$457K
Francisco KerdelMiami$2.1M
Brad GlickMargate$2M
Robert KirsnerMiami$1.4M
John MinniStuart$1.4M
Gil YosipovitchMiami$1M
Shino Bay AguileraFt Lauderdale$1M
Robert SnyderPembroke Pines$1M
Marc IngleseTallahassee$989K
Jeremy GreenCoral Gables$952K

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →